Prognostic relevance of 46 clinical, "classical" laboratory and oncological parameters in patients with advanced non-small cell lung cancer.

被引:0
|
作者
Holden-rieder, S
von Pawel, J
Heinemann, V
Raith, H
Feldmann, K
Stenman, UH
Nagel, D
Stieber, P
机构
[1] Univ Munich, Klinikum Grosshadern, Inst Clin Chem, D-8000 Munich, Germany
[2] Asklepios Hosp, Gauting, Germany
[3] Univ Munich, Klinikum Grosshadern, Med Clin 2, D-8000 Munich, Germany
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:669S / 669S
页数:1
相关论文
共 50 条
  • [31] Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.
    Karabou, Abdoulaye
    Bisseux, Laurence
    Pavese, Ida
    Collon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [33] Prognostic Factors Affecting Survival in Advanced Non-Small Cell Lung Cancer Patients
    Songur, Necla
    Kuru, Bekir
    Ok, Ugur
    TURKISH THORACIC JOURNAL, 2005, 6 (02) : 91 - 97
  • [34] Prognostic factors in older patients with advanced non-small cell lung cancer in China
    Su, Qiang
    Sun, Yu-Ping
    Liu, Ye-Hui
    Li, Zhe
    Yang, Hong-Yan
    Sun, Zhi-Gang
    Cao, Bang-Wei
    Jia, Ji-Hui
    TUMORI, 2014, 100 (01) : 69 - 74
  • [35] Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
    Wang, Chin-Chou
    Tseng, Chia-Cheng
    Chang, Huang-Chih
    Huang, Kuo-Tung
    Fang, Wen-Feng
    Chen, Yu-Mu
    Yang, Cheng-Ta
    Hsiao, Chang-Chun
    Lin, Meng-Chih
    Ho, Chi-Kung
    Yip, Hon-Kan
    ONCOTARGET, 2017, 8 (44) : 75952 - 75967
  • [36] Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer
    Ran, Fanglan
    Liu, Qjn
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (06) : 1674 - 1679
  • [37] Affordability of drug treatment in advanced non-small cell lung cancer.
    Chou, Yi-Ting
    Lafata, Jennifer Elston
    Farley, Joel
    Stinchcombe, Tom
    Proctor, Amber
    Dusetzina, Stacie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
    Di Maio, Massimo
    Signoriello, Simona
    Morabito, Alessandro
    Rossi, Antonio
    Maione, Paolo
    Piantedosi, FrancoVito
    Bilancia, Domenico
    Cigolari, Silvio
    Barbera, Santi
    Gebbia, Vittorio
    Daniele, Bruno
    Robbiati, Sergio Federico
    Illiano, Alfonso
    Ceribelli, Anna
    Carrozza, Francesco
    Favaretto, Adolfo
    Piazza, Elena
    Piccirillo, Maria Carmela
    Daniele, Gennaro
    Giordano, Pasqualina
    Costanzo, Raffaele
    Sandomenico, Claudia
    Rocco, Gaetano
    Gallo, Ciro
    Perrone, Francesco
    Gridelli, Cesare
    LUNG CANCER, 2012, 76 (03) : 457 - 464
  • [39] Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer
    Leung, Elaine Y. L.
    Scott, Hazel R.
    McMillan, Donald C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 655 - 662
  • [40] Inflammatory prognostic biomarkers in advanced non-small cell lung cancer
    Machado, D.
    Marques, C.
    Dias, M.
    Campainha, S.
    Barroso, A.
    PULMONOLOGY, 2019, 25 (03): : 181 - 183